Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow journalArticle 2017 Blanchard, P.; Menard, C.; Frank, S. J.
Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research journalArticle 2016 Blanchard, P.; Garden, A. S.
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients journalArticle 2019 Honore, C.; Delhorme, J. B.; Nassif, E.; Faron, M.; Ferron, G.; Bompas, E.; Glehen, O.; Italiano, A.; Bertucci, F.; Orbach, D.; Pocard, M.; Quenet, F.; Blay, J. Y.; Carrere, S.; Chevreau, C.; Mir, O.; Le Cesne, A.
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials journalArticle 2015 Faron, M.; Pignon, J. P.; Malka, D.; Bourredjem, A.; Douillard, J. Y.; Adenis, A.; Elias, D.; Bouché, O.; Ducreux, M.
[Hypofractionad radiotherapy for elderly with head and neck cancer] journalArticle 2018 Ortholan, C.; Auperin, A.; Mertens, C.; Le Caer, H.; Guigay, J.
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial journalArticle 2016 Piperno-Neumann, S.; Le Deley, M. C.; Redini, F.; Pacquement, H.; Marec-Berard, P.; Petit, P.; Brisse, H.; Lervat, C.; Gentet, J. C.; Entz-Werle, N.; Italiano, A.; Corradini, N.; Bompas, E.; Penel, N.; Tabone, M. D.; Gomez-Brouchet, A.; Guinebretiere, J. M.; Mascard, E.; Gouin, F.; Chevance, A.; Bonnet, N.; Blay, J. Y.; Brugieres, L.; Sarcoma Group of, Unicancer; French Society of Pediatric, Oncology; French Sarcoma, Group
[Oral cavity cancers among young people: Clinical results and prognostic analysis] journalArticle 2016 Blanchard, P.; El Khoury, C.; Temam, S.; Casiraghi, O.; Mirghani, H.; Levy, A.; Gorphe, P.; Even, C.; De Felice, F.; Nguyen, F.; Janot, F.; Tao, Y.
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group journalArticle 2016 Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R.
Prognostic value of the texture analysis parameters of the initial computed tomographic scan for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer journalArticle 2019 Vandendorpe, B.; Durot, C.; Lebellec, L.; Le Deley, M. C.; Sylla, D.; Bimbai, A. M.; Amroun, K.; Ramiandrisoa, F.; Cordoba, A.; Mirabel, X.; Hoeffel, C.; Pasquier, D.; Servagi-Vernat, S.
Mining the coding and non-coding genome for cancer drivers journalArticle 2015 Li, J.; Drubay, D.; Michiels, S.; Gautheret, D.
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials journalArticle 2017 Arnold, D.; Lueza, B.; Douillard, J. Y.; Peeters, M.; Lenz, H. J.; Venook, A.; Heinemann, V.; Van Cutsem, E.; Pignon, J. P.; Tabernero, J.; Cervantes, A.; Ciardiello, F.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group journalArticle 2016 Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R.
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management] journalArticle 2015 Luporsi, E.; Bellocq, J. P.; Barrière, J.; Bonastre, J.; Chetritt, J.; Le Corroller, A. G.; de Cremoux, P.; Fina, F.; Gauchez, A. S.; Lamy, P. J.; Martin, P. M.; Mazouni, C.; Peyrat, J. P.; Romieu, G.; Verdoni, L.; Mazeau-Woynar, V.; Kassab-Chahmi, D.
Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients journalArticle 2017 Boros, A.; Lacroix, L.; Lacas, B.; Adam, J.; Pignon, J. P.; Caramella, C.; Planchard, D.; de Montpreville, V.; Deutsch, E.; Levy, A.; Besse, B.; Le Pechoux, C.
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab journalArticle 2016 Hua, C.; Boussemart, L.; Mateus, C.; Routier, E.; Boutros, C.; Cazenave, H.; Viollet, R.; Thomas, M.; Roy, S.; Benannoune, N.; Tomasic, G.; Soria, J. C.; Champiat, S.; Texier, M.; Lanoy, E.; Robert, C.
Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy journalArticle 2018 Ou, D.; Adam, J.; Garberis, I.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J. Y.; Deutsch, E.; Tao, Y.
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) journalArticle 2015 Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C.
Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial journalArticle 2017 Caron, O.; Frebourg, T.; Benusiglio, P. R.; Foulon, S.; Brugières, L.
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment journalArticle 2017 Annede, P.; Gouy, S.; Mazeron, R.; Bentivegna, E.; Maroun, P.; Petit, C.; Dumas, I.; Leary, A.; Genestie, C.; Lhomme, C.; Deutsch, E.; Morice, P.; Pautier, P.; Haie-Meder, C.; Chargari, C.
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study) journalArticle 2015 Raynaud, C.; Greillier, L.; Mazieres, J.; Monnet, I.; Mastroianni, B.; Robinet, G.; Fraboulet, G.; Dixmier, A.; Berard, H.; Lamy, R.; Letreut, J.; Lena, H.; Oliviero, G.; Botta, S.; Vergnenegre, A.; Borget, I.; Chouaid, C.
Early PSA level decline is an independent predictor of biochemical and clinical control for salvage postprostatectomy radiotherapy journalArticle 2015 Blanchard, P.; Bakkour, M.; De Crevoisier, R.; Levy, A.; Baumert, H.; Patard, J. J.; Wibault, P.; Fizazi, K.; Bossi, A.
In Regard to Arthurs et al journalArticle 2017 Blanchard, P.; Garden, A. S.
Post Radiation Grade 3 neuroendocrine carcinoma (PRNEC): a new entity? journalArticle 2019 Hadoux, J.; Blanchard, P.; Scoazec, J. Y.; Burtin, P.; Planchard, D.; Malka, D.; Berdelou, A.; Boige, V.; Duvillard, P.; Leboulleux, S.; Faron, M.; Tselikas, L.; Deutsch, E.; Ducreux, M.; Baudin, E.
[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB] journalArticle 2015 Ezzalfani, M.; Dugue, A.; Mollevi, C.; Pulido, M.; Bonnetain, F.; Filleron, T.; Gal, J.; Gauthier, M.; Le Deley, M. C.; Le Tourneau, C.; Medioni, J.; Nguyen, J. M.; Chabaud, S.; Teixeira, L.; Thivat, E.; You, B.; Kramar, A.; Paoletti, X.
Treatment challenges in and outside a network setting: Head and neck cancers journalArticle 2018 Orlandi, E.; Alfieri, S.; Simon, C.; Trama, A.; Licitra, L.
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30 journalArticle 2016 Blanchard, P.; Briganti, A.; Bossi, A.
Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Breuskin, I.; Temam, S.; Tao, Y.; Janot, F.
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial journalArticle 2018 Arnedos, M.; Bayar, M. A.; Cheaib, B.; Scott, V.; Bouakka, I.; Valent, A.; Adam, J.; Leroux-Kozal, V.; Marty, V.; Rapinat, A.; Mazouni, C.; Sarfati, B.; Bieche, I.; Balleyguier, C.; Gentien, D.; Delaloge, S.; Lacroix-Triki, M.; Michiels, S.; Andre, F.
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic journalArticle 2016 Delaloge, S.; Bonastre, J.; Borget, I.; Garbay, J. R.; Fontenay, R.; Boinon, D.; Saghatchian, M.; Mathieu, M. C.; Mazouni, C.; Rivera, S.; Uzan, C.; Andre, F.; Dromain, C.; Boyer, B.; Pistilli, B.; Azoulay, S.; Rimareix, F.; Bayou el, H.; Sarfati, B.; Caron, H.; Ghouadni, A.; Leymarie, N.; Canale, S.; Mons, M.; Arfi-Rouche, J.; Arnedos, M.; Suciu, V.; Vielh, P.; Balleyguier, C.
Impact of experience in breast cancer surgery on survival: the role of quality of care in a registry-based cohort journalArticle 2019 Taban, F.; Elia, N.; Rapiti, E.; Rageth, C.; Fioretta, G.; Benhamou, S.; Than Lam, G.; David-Montefiore, E.; Bouchardy, C.
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours journalArticle 2015 Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X.
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy journalArticle 2018 Slimano, F.; Netzer, F.; Borget, I.; Lemare, F.; Besse, B.
Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy journalArticle 2017 Annede, P.; Seisen, T.; Klotz, C.; Mazeron, R.; Maroun, P.; Petit, C.; Deutsch, E.; Bossi, A.; Haie-Meder, C.; Chargari, C.; Blanchard, P.
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic journalArticle 2016 Delaloge, S.; Bonastre, J.; Borget, I.; Garbay, J. R.; Fontenay, R.; Boinon, D.; Saghatchian, M.; Mathieu, M. C.; Mazouni, C.; Rivera, S.; Uzan, C.; Andre, F.; Dromain, C.; Boyer, B.; Pistilli, B.; Azoulay, S.; Rimareix, F.; Bayou el, H.; Sarfati, B.; Caron, H.; Ghouadni, A.; Leymarie, N.; Canale, S.; Mons, M.; Arfi-Rouche, J.; Arnedos, M.; Suciu, V.; Vielh, P.; Balleyguier, C.
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study journalArticle 2015 Libé, R.; Borget, I.; Ronchi, C. L.; Zaggia, B.; Kroiss, M.; Kerkhofs, T.; Bertherat, J.; Volante, M.; Quinkler, M.; Chabre, O.; Bala, M.; Tabarin, A.; Beuschlein, F.; Vezzosi, D.; Deutschbein, T.; Borson-Chazot, F.; Hermsen, I.; Stell, A.; Fottner, C.; Leboulleux, S.; Hahner, S.; Mannelli, M.; Berruti, A.; Haak, H.; Terzolo, M.; Fassnacht, M.; Baudin, E.
Cardiac troponin I elevation and overall survival among cancer patients receiving investigational compounds during phase I trials journalArticle 2016 Hollebecque, A.; Lanoy, E.; Troallen, F.; Soulat-Dufour, L.; Massard, C.; Bahleda, R.; Varga, A.; Gazzah, A.; Postel-Vinay, S.; Ribrag, V.; Deutsch, E.; Angevin, E.; Boccara, F.; Cohen, A.; Soria, J. C.; Ederhy, S.
Mortality analyses in the updated French cohort of uranium miners (1946-2007) journalArticle 2015 Rage, E.; Caer-Lorho, S.; Drubay, D.; Ancelet, S.; Laroche, P.; Laurier, D.
Patients' perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study journalArticle 2017 Bredart, A.; Bodson, S.; Le Tourneau, C.; Flahault, C.; Bonnetain, F.; Beaudeau, A.; Coquan, E.; Dolbeault, S.; Paoletti, X.
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial journalArticle 2016 Krol, A.; Ferrer, L.; Pignon, J. P.; Proust-Lima, C.; Ducreux, M.; Bouche, O.; Michiels, S.; Rondeau, V.